Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Natrion | 2026 | Undisclosed | Undisclosed | Binghamton |
| PerPlant | 2026 | Seed | Undisclosed | Copenhagen |
| Oklo | 2026 | Post-IPO Equity | Undisclosed | Santa Clara |
| Patientory | 2026 | Venture - Series Unknown | Undisclosed | Atlanta |
| Confidentialmind | 2026 | Seed | Undisclosed | Espoo |
| Naturbeads | 2026 | Grant | $9.9M | Bath |
| Neurava | 2026 | Grant | $1.6M | Baltimore |
| MuukTest | 2026 | Grant | $3.1M | Raleigh |
| UMNAI | 2026 | Pre-Seed | $1.0M | London |
| Surf Therapeutics | 2026 | Venture - Series Unknown | $6.0M | Austin |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 1 | Natrion | Undisclosed | Undisclosed | Binghamton, United States |
| 2 | PerPlant | Seed | Undisclosed | Copenhagen, Denmark |
| 3 | Oklo | Post-IPO Equity | Undisclosed | Santa Clara, United States |
| 4 | Patientory | Venture - Series Unknown | Undisclosed | Atlanta, United States |
| 5 | Confidentialmind | Seed | Undisclosed | Espoo, Finland |
| 6 | Naturbeads | Grant | $9.9M | Bath, United Kingdom |
| 7 | Neurava | Grant | $1.6M | Baltimore, United States |
| 8 | MuukTest | Grant | $3.1M | Raleigh, United States |
| 9 | UMNAI | Pre-Seed | $1.0M | London, United Kingdom |
| 10 | Surf Therapeutics | Venture - Series Unknown | $6.0M | Austin, United States |
Natrion is developing scalable solid-state electrolytes to enable the mass adoption of EVs.
PerPlant is a deep-ag tech startup building camera-based agronomic sensors for tractor and agricultural drones.
Oklo specializes in designing and developing small modular reactors for advanced fission power plants.
Patientory is a patient data platform that empowers individuals to control their health data and earn personalized rewards.
Confidentialmind is a B2B software company that provides a secure AI platform for enterprises.
Naturbeads is scaling up the technology to manufacture cellulose beads and replace plastic microbeads intentionally added to many products
Neurava has developed wearable diagnostics for epilepsy patients including those at risk of SUDEP.
MuukTest is a software testing platform powered by AI that increases Software Devs testing productivity.
UMNAI specializes in neuro-symbolic machine learning and artificial intelligence and have created Hybrid Intelligence products.
Surf Therapeutics is a clinical-stage firm leading the development of non-invasive ultrasound neuromodulation technology.
Clean Valley CIC is a group of entrepreneurs, engineers and environmental scientists with a nature-inspired ideas for Canadian Innovation.
Starling develops predictive technology to identify chronic illnesses earlier.
AgZen develops pesticide sprays stick to plants which reduces pollution and helps farmers save.
Amulet provides consumer food allergen sensors that helps in testing for common allergenic ingredients in seconds.
ARMR Systems designs wearable first response hemorrhage control solutions to stop the bleeding anytime, anywhere.
Folia Health is a platform that captures and shares secure health and symptom data for users.
Nymiz provides a definitive solution to ensure compliance with the GDPR regulations.
Yeastime's value proposition is its innovative retrofitting ultrasound technology, which accelerates fermentation by up to 30%.
Organizational Management Platform for K-12 Schools.
RenewCO2 is a research company that develops processes for converting CO2 into polymers and chemicals.
H2Ok Innovations transforms the operations of food and beverage factories through in-line sensors and AI solutions.
Beewise offers robotic beehives that utilizes AI-powered precision robotics with minimal human intervention.
Construction Technology. Using sensors to capture the physical reality of the jobsite, and AI to optimise it.
ClearLeaf uses patent-pending technology, organic certified in the EU and Japan, to control fungi and bacteria in agriculture.
PATH EX has developed a proprietary technology to selectively separate and capture bacteria and toxins from human blood.
MassChallenge has invested in 807 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
MassChallenge's top investment sectors include Artificial Intelligence (AI), Health Care, AgTech, Software, Renewable Energy. The firm invests across 54 different industry categories.
Among tracked funding rounds, Beewise received $50.0M in a Series D round. MassChallenge's total known invested capital is $3.4B.
MassChallenge's average investment size is $6.6M across its portfolio of 807 companies.
Recent MassChallenge portfolio additions include Natrion, PerPlant, Oklo, Patientory, Confidentialmind. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors